Source News

AI-powered Nigerian news aggregation with bias detection and multi-viewpoint analysis.

Quick Links

Home
Timeline
Search

About

About Us
Privacy Policy
Terms of Service

Built with AI-powered news intelligence

Source News

Timeline Event Map

All Politics Business Sports Technology Entertainment Health General

Source News

AI-powered Nigerian news aggregation with bias detection and multi-viewpoint analysis.

Quick Links

Home
Timeline
Search

About

About Us
Privacy Policy
Terms of Service

Built with AI-powered news intelligence

Oxford begins first human trial of new Lassa Fever vaccine - Source News

Back to Home

Oxford begins first human trial of new Lassa Fever vaccine

Premium Times•3 months ago•centre•Credibility: 85/100

Thirty-one healthy adults aged 18 to 55 will take part in the trial in Oxford, while a second phase-1 trial is expected to begin in Ghana early 2026. The post Oxford begins first human trial of new Lassa Fever vaccine appeared first on Premium Times Nigeria.

Read full article at source

Oxford begins first human trial of new Lassa Fever vaccine

Community Reactions

AI-Powered Insights

Discussion (0)

Related Stories

Nigeria launches 1st immunotherapy trial for colorectal cancer

Oil & gas executive turned lifeline for vulnerable patients, earns continental humanitarian nomination

Yebu: FCT community where pregnant women travel 11km for health services

Taraba, World Bank strengthen primary healthcare with statewide logistics distribution

Lassa Fever: Benue records death of 10 health workers, five doctors affected

Ex-UCH CMD Seeks Collaboration to Tackle Bone Diseases in Nigeria